Haider, S. A., Yadav, A., Perry, C., Su, L., Akanbi, O., Kudaravalli, P., . . . Barrett, T. A. (2020). Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease. Therap Adv Gastroenterol.
Citação norma ChicagoHaider, Syedreza A., et al. "Ustekinumab Dose Escalation Improves Clinical Responses in Refractory Crohn’s Disease." Therap Adv Gastroenterol 2020.
MLA CitationHaider, Syedreza A., et al. "Ustekinumab Dose Escalation Improves Clinical Responses in Refractory Crohn’s Disease." Therap Adv Gastroenterol 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.